Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
17.36
+0.56 (3.33%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $32.63 million as of April 29, 2025. Its market cap has increased by 367.52% in one year.
Market Cap
32.63M
Enterprise Value
22.61M
1-Year Change
367.52%
Ranking
Category
Stock Price
$17.36
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $32.63M, a decrease of -43.91%. That is a compound annual growth rate of -22.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2025 | 32.63M | 26.34% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 778.70B |
| UnitedHealth Group | 379.65B |
| Johnson & Johnson | 373.01B |
| AbbVie | 337.43B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 224.32B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |